TMUB1 and cancer: TMUB1 was found to bind non-glycosylated PD-L1 in the endoplasmic reticulum and recruit STT3A to promote glycosylation of PD-L1, resulting in its protection from being ubiquitinated upon HUWE1 binding and ultimately increasing the levels of PD-L1 in different cancer types.